Assessment of Cytotoxicity on Moringa Olifera Against Ehrlich Ascites Carcinoma in Swiss Albino Mice.

NAGARAJA SURYADEVARA, Gokila Devi, Gopinath Gopinath




The present study determines the potent cytotoxic and antitumor properties of methanolic extract of Moringa oleifera leaves. The leaves were collected from in and around Tiruchengode of Nammakal district of Tamilnadu. The collected leaves were shade dried and powdered and the Methanolic extract was extracted using the soxhlet apparatus. In-vitro cytotoxicity study was done by Tryphan Blue Dye Exclusion method and MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5- diphenyltetrazolium bromide) assay. In short term cytotoxicity study by Tryphan Blue Dye Exclusion method the IC50 value against EAC cell lines was found to be 163.91 µg/ml. In Long term cytotoxicity study by MTT assay the IC50 value against Normal Mouse Embryonic Fibroblast (NIH 3T3) was found to be 260.85 µg/ml for Human Cervical Cancer cells (HeLA) was 182.41 µg/ml for Human Laryngeal Epithelial Carcinoma (HeP-2) was 195.93. µg/ml and for Human Liver Cancer cells (HepG2) was 168.61 µg/ml. The MST of control group was 17.33 ± 1.53 days, whereas it was 43.67 ± 1.15, 23.67 ± 1.53 and 33.33 ± 1.53 days for the groups treated with MMO (200 and 400mg/kg) and 5-FU respectively (0.001 & 0.001). The increase in life span of Tumour bearing mice treated with MMO and 5-FU was found to be 36. 75, 92.78 and 152.84 respectively. Haematological parameters of tumour bearing mice on the day 14 were showed significant changes when compared to normal mice. The total WBC count, protein and PCV were found to increase with a reduction in the hemoglobin content of RBC. At the same time interval, MMO (200 and 400mg/kg) treatment could change these parameters near to normal. Maximum alternation occurred in the MMO treatment at the dose of (400mg/kg). There was a significant reduction in the Tumour volume of mice treated with MMO (200 and 400 mg/kg/p.o.). The Tumour volume of control animals was 2. 92 ± 0.12 ml where it was 2.55 ± 0.11 ml and 1.82 ± 0.04 ml for the groups treated with MMO (200 and 400mg/kg/p.o) respectively (P < 0.01 & 0.005). Thus the present study provides clear evidence, that the extract of Moringa olifera shows effective cytotoxicity against   Ehrlich ascites carcinoma (EAC) cells in Swiss albino mice. A further study of the active principles and mechanism of action of the Methanolic extract of Moringa Olivera at the molecular level was needed. 


Ehrlich ascites carcinoma (EAC); Human Liver Cancer cells (HepG2); Human Cervical Cancer cells (HeLA); MTT;

Full Text:



Anwar, Bhanger,. Moringa oleifera: A food plant with multiple medicinal uses. Phytother. Res, 2007.17– 25.

Purwall L, Pathak AK, Jain UK ., In vivo anticancer activity of the leaves and fruits of Moringa oleifera on mouse. Pharmacologyonline 2010. 1: 655-65.

Fakurazi S, Sharifudin SA, ArulselvanP,. Moringa oleifera hydroethanolic extracts effecively alleviateacetaminophen-induced hepatotoxicity in experimental rats through their antioxidant nature. Int. J of pharma tech res. 2012.17: 8334-50.

Zohara, Yaniv, Bachrach., Contribution of selected medicinal plants for cancer prevention and therapy. Scientific Journal of the Faculty of Medicine. 2012. 29(3):117-23.

Basset J, DennyJ, Jeffery JH, Mendham J,. Vogel’s Text Book of Quantitative Inorganic Analysis. ELBS - Longman, Essex, UK. Edn. 1985. 4: 196.

Hebert, E., Brain. and Ellery, W., Kenneth. Text Book of Practical Pharmacognosy. Baillere, London. 1984. 4: 363-8.

Harbourne JB,. Phytochemical Methods- A Guide to Modern Techniques of Plant Analysis. Chapman and Hall, London. Edn. 1984. 2: 4-120.

Kokate CK, Purohit AP, Gokhale SB,. Hematologic complications of cancer chemotherapy. Pharmacognosy. Nirali Prakasan, Pune. 1990. 123-8.

Sunila, ES, Kuttan G,. Immunomodulatory and antitumor activity of Piper longum Linn and piperin. J Ethnopharmacol . 2004.90: 339-46.

Vijayan P, Vinod Kumar S, Dhanaraj SA, Mukherjee, PK, Suresh,. In vitro cytotoxicity and antitumor properties of Hypericum mysorense and Hypericum patulum. Phytother Res. 2003.17: 952-6.

Ramnath V, Girija kuttan, Ramadasan kuttan., Antitumor effect of abrin on transplanted tumors in mice. Indian J. Physiol. Pharmacol. 2002. 46: 69-77.

Rajkapoor B, Murugesh N, Lalitha K, Krishna DR,. Cytotoxic activity of flavone glycoside from the stem of Indigofera aspalathoides Vahl. J Nat Med. 2007. 61: 80-3.

Nidhi Agarwal,. Natural herbs as anticancer drugs. Int.J.PharmTech. 2012. 4: 1142- 53.

Sumitra Chanda, Krunal Nagani., In vitro and in vivo Methods for Anticancer Activity Evaluation and Some Indian Medicinal Plants Possessing Anticancer Properties: An Overview. 2013. 2 : 140 –52.

Picheswararao Polu, Udupa Nayanabhirama, Saleemulla Khan., Herbal medicinal plants as an anticancer agent. Annals of Phytomedicine 2015. 4(1): 37-45

Sathya TN., Moringa oleifera Lam. leaves prevent Cyclophosphamide- induced micronucleus and DNA damage in mice. Int. Jou. of Phytomedicine. 2010. 2: 147-54.

Alex D, Lam IK, Lin Z, Lee SMY,. Indirubin shows antiangiogenic activity in an in vivo zebra fish model and an in vitro HUVEC models. J Ethnopharmacol. 2010.131: 242 - 7.

Han R,. Highlights on the studies of anticancer drugs derived from plants in China. Stem Cells. 1994. 12: 53-63.

Awadh Ali, Julich WD, Kusnick C, Lindequist U., Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J Ethnopharmacol 2001. 74: 173-9.

Rajkapoor B, Murugesh N, Chodon D, Sakthisekaran D., Chemoprevention of N-Nitrosodiethylamine induced phenobarbitol promoted liver tumors in rats by extract of Indigofera aspalathoides. Biol Pharm Bull. 2005.28: 364-6.

Rajkapoor B, Jayakar B, Murugesh., Antitumor activity of Indigofera aspalathoides on Ehrlich ascites carcinoma in mice. Indian J Pharmacol. 2004. 36: 38-40.

Eman Noaman , Nadia fahmy, Raafat Yousri,. Evaluation of the antitumour and radiosynthestizing activity of a novel quinoline derivative as a histone deacetylase inhibitor. J. of cancer theraphy, 2011. 2: 567-78.

Meenakshi VK, Paripooranaselvi M, Senthamarai S, Gomathy S, Chamundeswari KP,. Antitumor and Immunomodulatory Activity of Phallusia nigra Savigny, 1816 Against Ehrlich Ascites Carcinoma. Res. Jou. Pharm. Sci. 2012. 1(2), 7-12.

Shimizu M, Azuma C, Taniguchi T, Murayama T,. Expression of cytosolic phospholipase A2α in murine C12 cells, a variant of L929 cells, induces arachidonic acid release in response to phorbol myristate acetate and Ca2++ ionophores, but not to tumor necrosis factor-α. .J Pharmacol Sci. 2004. 96: 324-32.

Segura JA, Barbero LG, Marquez J., Ehrlich ascites tumor unbalances splenic cell population and reduces responsiveness of T cells to Staphylococcus aureus enterotoxin B stimulation. Immunol Lett. 2000. 74: 111-15.

Fecchio D, Sirois P, Russo M, Jancar S,. Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity. Inflammation. 1990. 14: 125-32.

Marklund S, Marklund G,. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974. 47: 469-74.

Price VE, Greenfield RE., Anemia in cancer. Adv Cancer Res. 1958. 5: 199-200.

De Vita VT, Hellman S, Rosenburg SA,. Cancer: Principle and practice of oncology. 4th ed. J.B.Lippincott company. Philadelphia. 1993. 72-80.

Hoagland HC,. Hematologic complications of cancer chemotherapy. Semin Oncol. 1982. 9: 95-102.

Kintzios SE., Terrestrial plant derived anticancer agents and plant species used in anticancer research. Critic Rev Plant Sci. 2006. 25: 79-113.

Hirano T, Oka K, Akiba M,. Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol. 1989. 64: 69-78.

Brown JP,. A review of the genetic effect of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res. 1980. 75: 243-7.

Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H,. Flavonoids, dietery-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997.57: 2916-21.

Weber G, Shen F, Prajda N, Yeh YA, Yang H, Herenyiova M,. Increased signal transduction activity and down regulation in human cancer cells. Anticancer Res.1996. 16: 3271-82.

Man S, Gao W, Zhang Y, Huang L, Liu C., Chemical study and medical applications of saponins as anticancer agents. Fitoterapia. 2010. 81: 703-14.



  • There are currently no refbacks.

Copyright (c) 2017 Asian Pacific Journal of Cancer Biology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





Asia Pacific Organization for Cancer Prevention 

West Asia Organization for Cancer Prevention